Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement
December 03 2007 - 6:00AM
PR Newswire (US)
Digirad Expanding Portfolio of Partnerships with Centers of
Influence POWAY, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Digirad
Corporation (NASDAQ:DRAD), a leading provider of medical diagnostic
imaging systems and services to physicians' offices, hospitals and
imaging centers, today announced the signing of a letter of
agreement with The Methodist Hospital (Methodist) in Houston. Under
terms of the agreement, the fifth since the inception six months
ago of Digirad's centers of influence business strategy, Digirad
and Methodist will provide imaging and reading services,
respectively, to primary-care physicians in the Houston area who
are seeking to expand their practices with in-office imaging.
Through its mobile imaging operations, Digirad will bring
state-of-the-art equipment and qualified, trained personnel into
physicians' offices to perform the imaging. The patients' images
will be interpreted by Methodist physicians and the results sent
electronically to the referring physician. Digirad Chief Executive
Mark Casner said that the centers of influence model provides
better patient-care, because it combines the family physician's
patient-specific knowledge with the diagnostic expertise of
specialists at leading medical institutions. Methodist is one of
the country's leading academic medical centers and has earned
worldwide recognition for the latest innovations in medical,
surgical and diagnostic techniques. The hospital is ranked by U.S.
News & World Report as one of the nation's top hospitals in 14
of 16 specialties, with The Methodist DeBakey Heart Center being a
leader in cardiovascular care, which was pioneered by famed heart
surgeon Dr. Michael E. DeBakey. Methodist has a primary affiliation
with Weill Medical College of Cornell University. John Mahmarian
MD, medical director of nuclear cardiology at the Methodist DeBakey
Heart Center, stated: "Today's technology allows us to offer our
expertise and experience in diagnosing and treating heart disease
in ways that have never been possible in generations past. This
relationship puts all the right pieces in place so that at the
click of a button, we can see and diagnose patients across the city
or across the globe." Casner continued: "We welcome The Methodist
Hospital as a partner in assisting local-area physicians with
meeting the needs of their patients. Methodist is one of the top
hospitals in the nation and has a staff of physicians who are
highly regarded in their respective specialties, including
cardiology. This relationship promises to generate substantial
benefits for patients, including the clearest and most accurate
images available, readings by highly skilled specialists, and the
comfort of knowing that their own doctors will remain closely
involved in their care. "With this service, physicians can be more
effective at meeting patient scheduling needs while maintaining the
primary patient relationship," Casner added. "They will also be
able to offer their patients Methodist's well-established
experience and specialized expertise to provide needed diagnostic
services." About Digirad Digirad Corporation provides diagnostic
medical imaging systems and services to physicians' offices,
hospitals and imaging centers for cardiac, vascular, and general
imaging applications. Digirad's Cardius XPO line of nuclear imaging
cameras use patented solid-state technology and unique multi
(single, dual, triple) head design for superior performance and
advanced features for sharper digital images, faster processing,
compact size, lighter weight for portability, ability to handle
patients up to 500 pounds, and improved patient comfort compared to
standard nuclear cameras. Digirad's 2020tc general-purpose nuclear
imager has a small footprint and may also be configured for fixed
or mobile use to supplement primary imaging. Digirad's installed
base of equipment exceeds 450 systems; in addition, a mobile fleet
of more than 120 nuclear and ultrasound imaging systems is being
used in 22 states, primarily in the eastern, midwestern and
southwestern United States. For more information, please visit
http://www.digirad.com/. Digirad(R), Digirad Imaging Solutions(R),
and Cardius(R) are registered trademarks of Digirad Corporation.
Forward-Looking Statements Digirad cautions that statements
included in this press release that are not a description of
historical facts are forward-looking statements. You can identify
these statements by the fact that they do not relate strictly to
historical or current facts and use words such as "anticipate,"
"estimate," "expect," "project," "intend," "plan," "believe" and
other words and terms of similar meaning in connection with a
discussion of future operating or financial performance or events.
Examples of such statements include statements regarding terms of
the agreement, performance of parties under the agreement, and
patient benefits. The inclusion of these and other forward-looking
statements should not be regarded as a representation by Digirad
that any of its plans will be achieved. Actual results may differ
materially from those set forth in this press release due to the
risks and uncertainties inherent in Digirad's business including,
without limitation: the degree to which personnel changes and
related disruptions in our business activities may affect Digirad's
products, customers, work force, suppliers, and our overall
business prospects and operations; the degree to which Digirad's
camera systems and related services will be accepted by physicians
and hospitals some of whom may experience reliability issues or
technical problems; the ability of Digirad effectively to market,
sell and distribute its medical devices, and related services given
its limited capabilities in these areas; Digirad's ability to
manage risks relating to product liability, warranty claims,
recalls, property damage and personal injury with respect to its
imaging systems; and other risks detailed in Digirad's filings with
the U.S. Securities and Exchange Commission, including its Annual
Report on Form 10-K, Quarterly Reports on Form 10-Q, Form 8-K and
other reports. Given these uncertainties, readers are cautioned not
to place undue reliance on these forward-looking statements, which
speak only as of the date hereof. All forward-looking statements
are qualified in their entirety by this cautionary statement and
Digirad undertakes no obligation to revise or update this press
release including the forward-looking statements contained herein
to reflect events or circumstances after the date hereof or to
update the reasons actual results could differ materially from
those anticipated in these forward-looking statements, even if new
information becomes available in the future. DATASOURCE: Digirad
Corporation CONTACT: Company Contact, Mark Casner, CEO of Digirad
Corporation, +1-858-726-1600, ; or Investor Contact, Dan Matsui of
Allen & Caron, +1-949-474-4300, , for Digirad Corporation Web
site: http://www.digirad.com/
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jul 2023 to Jul 2024